Kaiyu Shang
State Key Laboratory Of Pathogenesis
Ueruemqi, 830000, China
Ueruemqi, 830000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Dual-targeting oral nanoparticle mucosal vaccine against brucella infection: co-targeting M cells and dendritic cells.
Journal: Journal of nanobiotechnology
Published: April 14, 2026
Tuft-cell-derived IL-25 regulates intestinal ILC2 in response to Brucella infection.
Journal: Frontiers in immunology
Published: October 25, 2025
Siglec-9 acts as an immune checkpoint marker on MDSCs in brucella infection.
Journal: Frontiers in cellular and infection microbiology
Published: June 23, 2025
Correction: Regulation of the tuft cell-ILC2 circuit in intestinal mucosal immunity.
Journal: Frontiers in immunology
Published: May 27, 2025
FcRn-Driven Nanoengineered Mucosal Vaccine with Multi-Epitope Fusion Induces Robust Dual Immunity and Long-Term Protection Against Brucella.
Journal: Vaccines
Published: March 31, 2025
Development and evaluation of novel Brucella diagnostic antigen protein ST.
Journal: BMC infectious diseases
Published: March 04, 2025
The role of notch signaling in regulating myeloid-derived suppressor cells: Implications in Cancer and autoimmune diseases.
Journal: International immunopharmacology
Published: February 06, 2025
Regulation of the tuft cell-ILC2 circuit in intestinal mucosal immunity.
Journal: Frontiers in immunology
Published: January 28, 2025
The development of a human Brucella mucosal vaccine: What should be considered?
Journal: Life sciences
Published: July 09, 2024
Novel dual-pathogen multi-epitope mRNA vaccine development for Brucella melitensis and Mycobacterium tuberculosis in silico approach.
Journal: PloS one
Published: July 05, 2024
Design of a novel EmTSP-3 and EmTIP based multi-epitope vaccine against Echinococcus multilocularis infection.
Journal: Frontiers in immunology
Published: April 30, 2024
Last Updated: 09/26/2026